Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine + CBT for Substance Dependent Teens with Depression
NCT00061113Phase 4Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Feb 2001
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Fluoxetine + CBT with Placebo + CBT (2 arms). Primary endpoints: Childhood Depression Rating Scale-Revised at 16 weeks, Clinical Global Impression Improvement at 16 weeks and 3 more. Started Feb 2001; status: completed.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00061113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00061113.